14-May-2024
No press releases found.
Health care is still very crowded but trades at a discount vs. history - BofA
Seeking Alpha News (Tue, 14-May 10:00 AM ET)
The SPDR S&P Pharmaceuticals ETF seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the S&P Pharmaceuticals Select Industry Index (the Index ).The S&P Pharmaceuticals Select Industry Index (the Index ) represents the pharmaceuticals segment of the S&P Total Market Index ( S&P TMI ). The S&P TMI is designed to track the broad U.S. equity market. The pharmaceuticals segment of the S&P TMI comprises the Pharmaceuticals sub-industry. The Index is one of twenty-one (21) of the S&P Select Industry Indices (the Select Industry Indices ), each designed to measure the performance of a narrow sub-industry or group of sub-industries determined based on the Global Industry Classification Standard ( GICS ).
SPDR S&P Pharmaceuticals ETF trades on the ARCA stock market under the symbol XPH.
As of May 14, 2024, XPH stock price climbed to $41.13 with 90,628 million shares trading.
XPH has a beta of 0.90, meaning it tends to be less sensitive to market movements. XPH has a correlation of 0.36 to the broad based SPY ETF.
XPH has a market cap of $199.49 million. This is considered a Micro Cap stock.
In the last 3 years, XPH stock traded as high as $53.82 and as low as $34.67.
XPH has underperformed the market in the last year with a price return of +0.5% while the SPY ETF gained +28.8%. XPH has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -6.2% and +3.4%, respectively, while the SPY returned +5.3% and +4.2%, respectively.
XPH support price is $40.64 and resistance is $41.42 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that XPH stock will trade within this expected range on the day.